Posterior tibial nerve stimulation in the management of overactive bladder: A prospective and controlled study;Electroestimulación del nervio tibial posterior para el tratamiento de la vejiga hiperactiva. Estudio prospectivo y controlado

Actas Urologicas Espanolas

Volumn 33, Issue 1, 2009, Pages 58-63

  Bellette, Patricia O ^a   Rodrigues Palma, Paulo C ^a   Hermann, Viviane ^a   Riccetto, Cássio ^a   Bigozzi, Miguel ^a   Olivares, Juan M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Electrical stimulation in posterior tibial nerve; OABq; Overactive Bladder

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROSTIMULATION THERAPY; FEMALE; HUMAN; MIDDLE AGED; OVERACTIVE BLADDER; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIBIAL NERVE;

ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; TIBIAL NERVE; URINARY BLADDER, OVERACTIVE;

EID: 67649791854     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(09)74003-3     Document Type: Article

References (13)

1. Abrams P. Padronizacao da terminología da funcao do trato urinario inferior. Neurourol Urodyn. 2002;21(2):167-178.
2. Hampel C, Wienhold D, Dahms SE, Thuroff JW. Heterogeneity in epidemiological investigations of bladder control problems: a problem of definition. BJU Int. 1999 Mar;83 Suppl 2:10-5.
3. Teloken C, Caraver F, Weber FA, Teloken PE, Moraes IF, Sogari PR, Graziottin TM. Overactive bladder: prevalence and implications in Brazil. European Urology. 2006., 49(6): 1087-1092.
4. McGuire E, Shi-Chun Z, Horwinsk ER, Lytton B. Treatment of motor and sensory detrusor instability by electrical stimulation. J Urology. 1983, 129(1):78-79.
5. Stoller M. Afferent nerve stimulation for pelvic floor dysfunction. European Urology, 37(2) :33, 2000.
6. Amarenco G, Ismael S, Even-Schneider, Raibaut P, Demaille-Wlodyka S, Parrate B, Kerdraon J. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urology 2003; 169(6):2210-2215.
7. Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkoevr J, Kurth H, Abrams P. Psychometric validation of an overactive bladder symptom and health- related quality of life questionnaire: the OAB-Q gual Life Res. 2002; ll(6):563-574
8. Govier F, Litwiller S, Nitti V, Kreder K, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory iver- active bladder: results of a multicenter study. J Urol. 2001:165 (4): 1193-1198.
9. Van Balken MR, Vergunst H, Bemelmans BLH. Prognostic factors for successful percutaneous tibial nerve stimulation Eur Urol. 2006:49(2) :360-365
10. Abrams P, Kelleher CJ.Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000 Jul; 6(11 Suppl) :S580-590
11. Chappie C. The contemporary pharmacological management of overactive bladder. Journal of obstetrics and gynecology, 19-28, 2006.
12. Van der Pal F, Van Balken MR, Heesakkers JPFA, Debruyne FMJ, Kiemeney LALM, Bemelmans BLH. Correlations between quality of life and voiding variables in patients treated with percutaneous tibial nerve stimulation. BJU Int. 2006 Jan; 97(1): 113-116.
13. Irwin D, Milson I, Kopp Z, Abrams P, Cardozo L. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six european countries. BJU Int. 2006;97(1):96-100.